background multivitamins are the most commonly used supplement in the developed worldrecent epidemiologic findings suggest that multivitamin use increases the risk of mortalityobjective we aimed to determine whether multivitaminmultimineral treatment used for primary or secondary prevention increases the risk of mortality in independently living adultsdesign we performed a metaanalysis of randomized controlled trialsmultiple electronic databases were systematically searched from march to october 2012randomized controlled primary or secondary prevention trials were considered for inclusioneligible trials investigated daily multivitaminmultimineral supplementation for 1 ycohorts described as institutionalized or as having terminal illness tertiary prevention were excludedthe number of deaths and the sample size of each study arm were extracted independently by 2 researcherstwentyone articles were included in the analysis which generated a total pooled sample of 91074 people and 8794 deathsthese trials were pooled in a metaanalysis and the outcomes were expressed as rrs and 95 cisresults the average age of the pooled sample was 62 y and the average duration of supplementation was 43 moacross all studies no effect of multivitaminmultimineral treatment on allcause mortality rr 098 95 ci 094 102 was observedthere was a trend for a reduced risk of allcause mortality across primary prevention trials rr 094 95 ci 089 100multivitaminmultimineral treatment had no effect on mortality due to vascular causes rr 101 95 ci 093 109 or cancer rr 096 95 ci 088 104no statistical evidence of heterogeneity or publication bias was observedconclusion multivitaminmultimineral treatment has no effect on mortality risk